Form 8-K - Current report:
SEC Accession No. 0001437749-26-021134
Filing Date
2026-06-18
Accepted
2026-06-18 16:01:04
Documents
13
Period of Report
2026-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20260615_8k.htm   iXBRL 8-K 48029
2 EXHIBIT 10.1 ex_976935.htm EX-10.1 147904
  Complete submission text file 0001437749-26-021134.txt   359195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20260618.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20260618_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20260618_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20260618_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20260615_8k_htm.xml XML 2833
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 261102379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)